William J. Bradshaw
Akebia Therapeutics (United States)(US)Massachusetts Institute of Technology(US)
Publications by Year
Research Areas
SARS-CoV-2 detection and testing, Aquaculture disease management and microbiota, COVID-19 epidemiological studies, Bacteriophages and microbial interactions, CRISPR and Genetic Engineering
Most-Cited Works
- → Bidirectional contact tracing could dramatically improve COVID-19 control(2021)161 cited
- → BACTERIAL ANTIGENS CROSS-REACTIVE WITH THE CAPSULAR POLYSACCHARIDE OF HÆMOPHILUS INFLUENZÆ TYPE b(1971)121 cited
- → Assessing the safety of new germicidalfar‐UVCtechnologies(2023)42 cited
- → Extreme genomic volatility characterizes the evolution of the immunoglobulin heavy chain locus in cyprinodontiform fishes(2020)23 cited
- → Bidirectional contact tracing dramatically improves COVID-19 control(2020)18 cited
- → Analysis of the first genetic engineering attribution challenge(2022)11 cited
- → Inferring the sensitivity of wastewater metagenomic sequencing for early detection of viruses: a statistical modelling study(2025)6 cited
- → Development of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic strategy for Alzheimer’s disease(2023)6 cited
- → Indoor air sampling for detection of viral nucleic acids(2025)6 cited
- → Metagenomic sequencing of composite airplane wastewater for surveillance of emerging viruses(2026)2 cited